Precipio, Inc. (NASDAQ:PRPO – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.14 and traded as low as $4.96. Precipio shares last traded at $5.19, with a volume of 1,954 shares.
Precipio Price Performance
The company has a debt-to-equity ratio of 0.01, a current ratio of 0.78 and a quick ratio of 0.62. The company has a 50 day moving average price of $5.76 and a 200 day moving average price of $6.14. The firm has a market cap of $7.63 million, a PE ratio of -1.52 and a beta of 1.27.
Precipio (NASDAQ:PRPO – Get Free Report) last released its quarterly earnings results on Tuesday, May 14th. The biotechnology company reported ($1.46) EPS for the quarter. Precipio had a negative return on equity of 46.12% and a negative net margin of 31.00%. The company had revenue of $3.43 million for the quarter.
About Precipio
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
Read More
- Five stocks we like better than Precipio
- What is the NASDAQ Stock Exchange?
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Best Stocks Under $10.00
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
